Isosceles Pharmaceuticals

The Opioid Crisis Kills One American Every Five Minutes, Costs Our Country $1 Trillion Per Year…
And The Problem Is Getting Worse!
Death by drug overdose – mainly from opioids like fentanyl – has more than doubled in recent years from about 44,000 in 2013, to over 107,000 in 2021…

It is now the #1 cause of death among Americans 18-45 according to the CDC.

That’s why in February 2022, the FDA published guidance around their current thinking about three specific topics: the development of non-opioid analgesic products for acute pain, labeling claims, and expedited programs as they pertain to this purpose.

What does this mean for investors?

A potential “open window” to own the next generation of blockbuster non-opioid pain management therapies…

And with it, the chance to reduce the impact of the opioid epidemic that costs the American people $1 trillion per year while killing more than 293 people each day (and climbing).

However, launching blockbuster drugs can be a long, expensive, and h

ClearingBid

Allowing everyone to participate in IPOs

The Initial Public Offering (IPO) process is broken.

Every year, the most innovative companies in the world go public, with tens of billions of dollars changing hands through a process invented over a century ago.

The main problem is access and transparency. IPO investing is only available to a handful of large institutions and banks. The pricing is based on the company’s financials, market conditions and expected demand, but in the end, the final price is decided in a “black box.”

Current pricing doesn’t reflect actual market demand.

The actual IPO pricing doesn’t happen when a company lists on a stock exchange…

… it happens the night before, when the company sells most of its shares to a handful of large, preferred investors.

As a result of inaccurate pricing and privileged access, when the company’s stock begins trading, it can POP 100% or more! This favors the institutions over the company and retail investors.

Just loo

Bluon

History
It all started with a crazy nuclear physicist. After his early scientific career got sidetracked, he spent a career in commercial real estate… until he decided it was time to get back to science. He had a thought… hmm all the R-22 replacements out there suck. Surely, we can create a better one!

Want to hear more about our history: Listen to a podcast here.

So we got to work! After 4 years of some hard core chemistry, R&D and real world testing on 100’s of formulas, we were able to create an entirely new refrigerant that worked, and it really worked! Along the way, we realized all the lab coat scientists creating refrigerants don’t actually test anything or talk to techs in the REAL WORLD – they relied almost exclusively on computer simulations. News flash, the world doesn’t operate that way!

After that experience, we knew why so many of the new refrigerants simply suck and cause so many problems when being installed in the field with no instructions or support. Nobody ever bothered t